IL126349A0 - Parapoxvirus vectors - Google Patents
Parapoxvirus vectorsInfo
- Publication number
- IL126349A0 IL126349A0 IL12634997A IL12634997A IL126349A0 IL 126349 A0 IL126349 A0 IL 126349A0 IL 12634997 A IL12634997 A IL 12634997A IL 12634997 A IL12634997 A IL 12634997A IL 126349 A0 IL126349 A0 IL 126349A0
- Authority
- IL
- Israel
- Prior art keywords
- parapoxvirus
- vectors
- parapoxvirus vectors
- Prior art date
Links
- 241000700639 Parapoxvirus Species 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4355—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from cestodes
- C07K14/43554—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from cestodes from Taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24241—Use of virus, viral particle or viral elements as a vector
- C12N2710/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ28628496 | 1996-03-29 | ||
PCT/NZ1997/000040 WO1997037031A1 (en) | 1996-03-29 | 1997-03-27 | Parapoxvirus vectors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL126349A0 true IL126349A0 (en) | 1999-05-09 |
Family
ID=19925703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12634997A IL126349A0 (en) | 1996-03-29 | 1997-03-27 | Parapoxvirus vectors |
Country Status (11)
Country | Link |
---|---|
US (1) | US20030013076A1 (hu) |
EP (1) | EP0904393A4 (hu) |
JP (1) | JP2000507449A (hu) |
KR (1) | KR20000005120A (hu) |
CN (1) | CN1217751A (hu) |
AU (1) | AU2182697A (hu) |
BR (1) | BR9708401A (hu) |
CA (1) | CA2250041A1 (hu) |
HU (1) | HUP9902438A3 (hu) |
IL (1) | IL126349A0 (hu) |
WO (1) | WO1997037031A1 (hu) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US7790856B2 (en) | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
DE19813774A1 (de) * | 1998-03-27 | 1999-09-30 | Max Planck Gesellschaft | Parapockenvirus-kodierter vaskulärer Endothelzell Wachstumsfaktor (PPV-VEGF) |
JP2003517275A (ja) * | 1998-11-02 | 2003-05-27 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | 哺乳動物vegfレセプター−2に結合し、これを活性化するオルフウイルスnz2由来の血管内皮細胞増殖因子様タンパク質 |
DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
AU782020B2 (en) | 1999-11-12 | 2005-06-30 | Oncolytics Biotech, Inc. | Viruses for the treatment of cellular proliferative disorders |
EP1303286B1 (de) * | 2000-07-11 | 2006-04-26 | Bayer HealthCare AG | Verwendung von stämmen des parapoxvirus ovis zur herstellung von antiviralen arzneimitteln und arzneimitteln gegen krebs |
DE10122451A1 (de) * | 2000-07-11 | 2002-04-04 | Bayer Ag | Verwendung von Stämmen des Parapoxvirus ovis zur Herstellung von antiviralen Arzneimitteln und Arzneimitteln gegen Krebs |
AU2002362072A1 (en) | 2001-12-07 | 2003-06-23 | Board Of Regents The University Of Texas System | Use a parapox b2l protein to modify immune responses to administered antigens |
US6752995B2 (en) * | 2002-04-15 | 2004-06-22 | Board Of Regents, The University Of Texas System | Nucleic acid and polypeptide sequences useful as adjuvants |
US6723329B2 (en) * | 2001-12-07 | 2004-04-20 | Board Of Regents, The University Of Texas System | Use of parapox B2L protein to modify immune responses to administered antigens |
MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
JP4311732B2 (ja) * | 2004-04-13 | 2009-08-12 | 株式会社リコー | 光ピックアップ装置及び光ディスク装置 |
WO2006066089A1 (en) | 2004-12-15 | 2006-06-22 | Neuralab Limited | Humanized amyloid beta antibodies for use in improving cognition |
WO2009017467A1 (en) | 2007-07-27 | 2009-02-05 | Elan Pharma International Limited | Treatment of amyloidogenic diseases |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
JP2013523175A (ja) | 2010-04-14 | 2013-06-17 | イーエムディー・ミリポア・コーポレーション | 高力価、高純度のウイルスストックの作製方法及びその使用方法 |
CN104878043B (zh) * | 2015-06-01 | 2017-12-05 | 石河子大学 | 羊口疮病毒毒力基因vir缺失突变株及其制备方法和应用 |
DE102015111756A1 (de) | 2015-07-20 | 2017-01-26 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Rekombinanter Orf-Virus-Vektor |
BR112018069371A2 (pt) | 2016-03-21 | 2019-01-22 | South Dakota Board Of Regents | construção de ácido nucleico, vetor, vacina ou composição imunogênica, método de entrega de uma vacina, método de produção de uma construção de ácido nucleico e método para conferir imunidade contra um antígeno |
CN107299087B (zh) * | 2016-04-15 | 2020-11-06 | 金宇保灵生物药品有限公司 | 用传代细胞系制备羊口疮病毒的方法 |
CN107287149B (zh) * | 2017-05-09 | 2020-12-29 | 杨凌博德越生物科技有限公司 | 一种用于羊口疮病毒增殖的永久细胞系及其建立方法 |
JP2021516957A (ja) | 2018-03-07 | 2021-07-15 | トランジェーヌTransgene | パラポックスウイルスベクター |
WO2024062098A1 (en) | 2022-09-23 | 2024-03-28 | Transgene | Recombinant pseudocowpox virus encoding an interleukin-12 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPM710194A0 (en) * | 1994-07-26 | 1994-08-18 | Commonwealth Scientific And Industrial Research Organisation | Virus vector |
DE59712852D1 (de) * | 1996-02-28 | 2007-07-19 | Bayer Healthcare Ag | Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen |
-
1997
- 1997-03-27 HU HU9902438A patent/HUP9902438A3/hu unknown
- 1997-03-27 KR KR1019980707762A patent/KR20000005120A/ko not_active Application Discontinuation
- 1997-03-27 WO PCT/NZ1997/000040 patent/WO1997037031A1/en not_active Application Discontinuation
- 1997-03-27 BR BR9708401-8A patent/BR9708401A/pt not_active Application Discontinuation
- 1997-03-27 AU AU21826/97A patent/AU2182697A/en not_active Abandoned
- 1997-03-27 JP JP9535166A patent/JP2000507449A/ja not_active Ceased
- 1997-03-27 CN CN97194373A patent/CN1217751A/zh active Pending
- 1997-03-27 EP EP97914678A patent/EP0904393A4/en not_active Withdrawn
- 1997-03-27 CA CA002250041A patent/CA2250041A1/en not_active Abandoned
- 1997-03-27 IL IL12634997A patent/IL126349A0/xx unknown
-
2001
- 2001-03-02 US US09/796,679 patent/US20030013076A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP9902438A2 (hu) | 1999-11-29 |
US20030013076A1 (en) | 2003-01-16 |
BR9708401A (pt) | 2000-01-04 |
AU2182697A (en) | 1997-10-22 |
JP2000507449A (ja) | 2000-06-20 |
WO1997037031A1 (en) | 1997-10-09 |
CA2250041A1 (en) | 1997-10-09 |
EP0904393A1 (en) | 1999-03-31 |
KR20000005120A (ko) | 2000-01-25 |
CN1217751A (zh) | 1999-05-26 |
HUP9902438A3 (en) | 2000-03-28 |
EP0904393A4 (en) | 1999-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL126349A0 (en) | Parapoxvirus vectors | |
HUP0001650A3 (en) | Improved expression vectors | |
HUP0000442A3 (en) | Lentiviral vectors | |
DE69708875D1 (en) | Elastomere mikrozelluläre polyurethanschäume | |
GB2310108B (en) | Handoff | |
DE59708678D1 (en) | Elastomere cycloolefincopolymere | |
IL117498A (en) | Valise | |
GB9601353D0 (en) | Stays | |
GB9610624D0 (en) | Stays | |
DE59712426D1 (en) | Thermoplastische elastomere kohlenmonoxid/olefin-copolymere | |
HUP9901287A3 (en) | Coin-checking arrangement | |
GB2314376B (en) | Stays | |
GB2334257B (en) | Rectroviral vectors | |
GB2331752B (en) | Vectors | |
GB9608125D0 (en) | Vectors | |
PL330823A1 (en) | Improved autoradiohraphy | |
GB9617214D0 (en) | Vector | |
PL316481A1 (en) | Electropneumatic pulsator | |
GB2350613B (en) | Vectors | |
GB9725311D0 (en) | Vectors | |
GB9725313D0 (en) | Vectors | |
GB2317576B (en) | Cycles | |
GB9422320D0 (en) | Vector | |
GB9612831D0 (en) | Spatial magnetic-interrogation | |
TW295111U (en) | Iron structure improvement |